Volume 16; Issue 9

Journal of Medical Economics

Volume 16; Issue 9

1

Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial

Majer, I. M., Gelderblom, H., van den Hout, W. B., Gray, E., Verheggen, B. G.

Journal:

Journal of Medical Economics

Year:

2013

Language:

english

File:

PDF, 336 KB

english, 2013

2

Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis

Bonafede, Machaon, Joseph, George J., Princic, Nicole, Harrison, David J.

Journal:

Journal of Medical Economics

Year:

2013

Language:

english

File:

PDF, 163 KB

english, 2013

3

Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients ≥75 and

Deitelzweig, Steve, Amin, Alpesh, Jing, Yonghua, Makenbaeva, Dinara, Wiederkehr, Daniel, Lin, Jay, Graham, John

Journal:

Journal of Medical Economics

Year:

2013

Language:

english

File:

PDF, 158 KB

english, 2013

4

Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies

Xie, Lin, Wei, Wenhui, Pan, Chunshen, Baser, Onur

Journal:

Journal of Medical Economics

Year:

2013

Language:

english

File:

PDF, 396 KB

english, 2013

5

Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients

Sharma, Amit, Ketteler, Markus, Marshall, Thomas S., Khan, Samina S., Schumock, Glen T.

Journal:

Journal of Medical Economics

Year:

2013

Language:

english

File:

PDF, 347 KB

english, 2013

6

Economic and clinical comparison of atypical depot antipsychotic drugs for treatment of chronic schizophrenia in the Czech Republic

Einarson, Thomas R., Zilbershtein, Roman, Skoupá, Jana, Veselá, Šárka, Garg, Madhur, Hemels, Michiel E. H.

Journal:

Journal of Medical Economics

Year:

2013

Language:

english

File:

PDF, 262 KB

english, 2013

7

Cost-effectiveness analysis of atypical long-acting antipsychotics for treating chronic schizophrenia in Finland

Einarson, Thomas R., Pudas, Hanna, Zilbershtein, Roman, Jensen, Rasmus, Vicente, Colin, Piwko, Charles, Hemels, Michiel E. H.

Journal:

Journal of Medical Economics

Year:

2013

Language:

english

File:

PDF, 383 KB

english, 2013

8

Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet

Belozeroff, Vasily, Lee, Andrew, Tseng, Spring, Chiroli, Silvia, Campbell, Jonathan D.

Journal:

Journal of Medical Economics

Year:

2013

Language:

english

File:

PDF, 194 KB

english, 2013

9

Using observational analysis of multiple sclerosis relapse to design outcomes-based contracts for disease-modifying drugs: a feasibility assessment

Lage, Maureen J., Carroll, Cathryn A., Fairman, Kathleen A.

Journal:

Journal of Medical Economics

Year:

2013

Language:

english

File:

PDF, 338 KB

english, 2013